Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Two new studies have been published that further focus attention on how the renin–angiotensin ...

The argument was elegant in its simplicity. Patients with high levels of renin had a vasoconstriction type of hypertension that was driven primarily by the actions of the renin-angiotensin system on ...

The renin-angiotensin system (RAS) remains a cornerstone of cardiovascular and renal physiology, orchestrating vital aspects of blood pressure regulation and fluid-electrolyte balance. At the heart of ...

Forbes contributors publish independent expert analyses and insights. I'm a medical journalist covering cardiology news. The enormous success of ACE inhibitors in hypertension and heart failure ...

New Orleans, La. (March 27, 2007) -- A combination of two medicines that act against the effects of the enzyme renin are more effective in lowering blood pressure than either of the medicines alone, ...

In a recent study posted to the medRxiv* preprint server, researchers conducted an umbrella review and meta-analysis of the renin-angiotensin-aldosterone system (RAAS) inhibitors' impact on ...

Initial evidence of the existence of renin, which is an angiotensinogenase enzyme secreted by the kidney, was presented to the medical community more than 100 years ago. Nevertheless, the significance ...

This is a preview. Log in through your library . Abstract Angiotensin II is the principle effector molecule of the renin angiotensin System (RAS). It exerts its various actions on the cardiovascular ...

[Updated]-- The European Medicines Agency said last week that it was initiating a review of the combined use of agents that block the renin-angiotensin system (RAS). The three classes of RAS-blocking ...

The FDA approved aliskiren, the first hypertension treatment that inhibits renin. Aliskiren (Tekturna, Novartis) is also the first, new type of hypertension drug approved by the FDA in more than a ...

Approximately one in five eligible patients hospitalized for ACS do not receive guideline-recommended ACE inhibitor or angiotensin receptor blocker therapies. Guidelines from the American College of ...